Video: COVID-19 vaccine's efficacy rate above 90%, claims Pfizer in first interim analysis from Phase 3 study
"Based on current projections we expect to produce globally up to 50 million COVID-19 vaccine doses in 2020 and up to 1.3 billion doses in 2021," said Pfizer.
Nov 09, 2020, 19:30 PM IST
Pfizer says acquiring biotech firm Medivation for $14 billion
Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday.
Aug 22, 2016, 17:41 PM IST
GVK Bio acquires US headquartered Vanta Bioscience
Contract research firm GVK Bio today signed a definitive agreement to acquire Vanta Bioscience for an undisclosed sum.
Nov 06, 2014, 17:59 PM IST
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for USD8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
Aug 24, 2014, 23:54 PM IST
